Abstract |
Previous studies demonstrated selective inhibition of the BCR-ABL (breakpoint cluster region-Abelson murine leukemia oncogene) tyrosine kinase by RNA interference in leukemic cells. In this study, we evaluated the effect of BCR-ABL small interfering RNA ( siRNA) and GFI1B siRNA silencing on chronic myeloid leukemia (CML) cells in myeloid blast crises. The GFI1B gene was mapped to chromosome 9 and is, therefore, located downstream of the BCR-ABL translocation in CML cells. Co-transfection of BCR-ABL siRNA and GFI1B siRNA dramatically decreased cell viability and significantly induced apoptosis and inhibited proliferation in K562 cells (P<0.0001) and primary advanced phase CML cells (P<0.0001) versus controls. Furthermore, combining of BCR-ABL siRNA and GFI1B siRNA significantly modified the expression of several relevant genes including Myc, MDR1, MRP1 and tyrosyl- phosphoproteins in primary CML cells. Our data suggest that silencing of both BCR-ABL siRNA and GFI1B siRNA is associated with an additive antileukemic effect against K562 cells and primary advanced CML cells, further validating these genes as attractive therapeutic targets.
|
Authors | M Koldehoff, J L Zakrzewski, D W Beelen, A H Elmaagacli |
Journal | Cancer gene therapy
(Cancer Gene Ther)
Vol. 20
Issue 7
Pg. 421-7
(Jul 2013)
ISSN: 1476-5500 [Electronic] England |
PMID | 23788109
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- GFI1B protein, human
- Proto-Oncogene Proteins
- RNA, Small Interfering
- Repressor Proteins
- Fusion Proteins, bcr-abl
|
Topics |
- Apoptosis
- Cell Proliferation
- Fusion Proteins, bcr-abl
(genetics, metabolism)
- Gene Expression
- Gene Knockdown Techniques
- Hematopoietic Stem Cells
(metabolism)
- Humans
- K562 Cells
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Proto-Oncogene Proteins
(genetics, metabolism)
- RNA Interference
- RNA, Small Interfering
(genetics)
- Real-Time Polymerase Chain Reaction
- Repressor Proteins
(genetics, metabolism)
|